These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [CD antigens and the differentiation of human lymphocytes]. Kuritani T; Negoro S; Kishimoto S Hum Cell; 1988 Sep; 1(3):282-8. PubMed ID: 2979205 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to rat leukocyte surface antigens, MHC antigens, and immunoglobulins. Puklavec MJ; Barclay AN Curr Protoc Immunol; 2001 May; Appendix 4():Appendix 4C. PubMed ID: 18432667 [TBL] [Abstract][Full Text] [Related]
5. Profiling CD antigens on leukaemias with an antibody microarray. Barber N; Gez S; Belov L; Mulligan SP; Woolfson A; Christopherson RI FEBS Lett; 2009 Jun; 583(11):1785-91. PubMed ID: 19298816 [TBL] [Abstract][Full Text] [Related]
6. Human leucocyte differentiation antigens: review of the CD nomenclature. Erber WN Pathology; 1990 Apr; 22(2):61-9. PubMed ID: 2235099 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Cobbold S; Metcalfe S Tissue Antigens; 1994 Mar; 43(3):137-54. PubMed ID: 8091414 [TBL] [Abstract][Full Text] [Related]
8. CD antigens 2001. Mason D; André P; Bensussan A; Buckley C; Civin C; Clark E; de Haas M; Goyert S; Hadam M; Hart D; Horejsí V; Meuer S; Morrissey J; Schwartz-Albiez R; Shaw S; Simmons D; Uguccioni M; van der Schoot E; Vivier E; Zola H Immunology; 2001 Aug; 103(4):401-6. PubMed ID: 11529929 [No Abstract] [Full Text] [Related]
9. Reference: CD Antigens 2002. Mason D; André P; Bensussan A; Buckley C; Civin C; Clark E; de Haas M; Goyert S; Hadam M; Hart D; Horejsí V; Meuer S; Morrissey J; Schwartz-Albiez R; Shaw S; Simmons D; Uguccioni M; van der Schoot E; Vivier E; Zola H J Immunol; 2002 Mar; 168(5):2083-6. PubMed ID: 11859091 [No Abstract] [Full Text] [Related]
10. [Classification of human leukocyte differentiation antigens by means of monoclonal antibodies and their clinical application]. Yokoyama M; Hara A Nihon Rinsho; 1990 Feb; 48 Suppl():738-54. PubMed ID: 2355606 [No Abstract] [Full Text] [Related]
11. Do some malignant melanoma cells share antigens with the myeloid monocyte lineage? Munzarová M; Rejthar A; Mechl Z Neoplasma; 1991; 38(4):401-5. PubMed ID: 1717856 [TBL] [Abstract][Full Text] [Related]
12. Cross-reactivity of monoclonal antibodies to defined human leucocyte differentiation antigens with bovine cells. Sopp P; Howard CJ Vet Immunol Immunopathol; 1997 May; 56(1-2):11-25. PubMed ID: 9220577 [TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibody therapy targeting surface antigens of leukemic cells]. Meng FY; Fu YB Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):441-3. PubMed ID: 15854546 [No Abstract] [Full Text] [Related]
19. [Current therapy of multiple sclerosis. Therapy with monoclonal antibodies to T-cell antigens (CD3, CD4, CD52)]. Schmidt S; Hohlfeld R Nervenarzt; 1996 Feb; 67(2):170-6. PubMed ID: 8851300 [TBL] [Abstract][Full Text] [Related]
20. Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies. Zola H Expert Opin Biol Ther; 2001 May; 1(3):375-83. PubMed ID: 11727512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]